1-3 of 3
Paul Moorehead
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study

Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Víctor Jiménez-Yuste, Benjamin M. Beckermann, Christophe Schmitt, Cedric Hermans, Giuliana Ventriglia, Jerzy Windyga, Anna Kiialainen, Roseline d'Oiron, Paul Moorehead, Vanda Teodoro, Amy D. Shapiro, Johannes Oldenburg
Journal: Blood
Blood (2021) 138 (Supplement 1): 343.
https://doi.org/10.1182/blood-2021-146009
Published: 2021
Journal Articles

Venous Thrombotic Events Are Independently Associated with Inferior Survival Outcome in Pediatric Cancer Patients: A Multicenter Study

Zara Forbrigger, Maggie Brown, Stefan Kuhle, Paul Moorehead, MD, Carol Digout, Ketan Kulkarni, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2153.
https://doi.org/10.1182/blood.V130.Suppl_1.2153.2153
Published: 2017
Journal Articles

Immune Tolerance Induction in Hemophilia A Patients Using Wilate® —a Canadian 10 Year Study (PREVAIL)

Paul Moorehead, MD, Mark J. Belletrutti, MD MSc, David Lillicrap, MD FRCPC, Robert J Klaassen, MD FRCPC, Manuel Carcao, MDMSc, Georges E. Rivard, MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 3679.
https://doi.org/10.1182/blood.V130.Suppl_1.3679.3679
Published: 2017